The invention provides a compound of formula (I):
wherein: R1-R5, m, n, p, and the bonds a and b represented by - - - have any of the values, specific values, or preferred values described in the specification; or a salt or solvate thereof. The invention also provides pharmaceutical compositions comprising such a compound, as well as intermediates and processes useful for preparing such a compound, and therapeutic methods including the administration of such a compound.
Disclosed are compounds of general structural formula (I), and use of the compounds, salts and solvates thereof, and pharmaceutical compositions containing the same in the treatment of a diesase, disorder, and/or condition in a mammal wherein a 5-HT receptor is implicated and modulation of a 5-HT function is desired.
The invetion provides a compound of formula (1), wherein: R1-R5, m, m, p, and the bonds a and b represented by --- have any of the values, specific values, or preferred values described in the specification; or a salt or solvate thereof. The invention also provides pharmaceutical compositions comprising such a compound, as well as intermediates and processes useful for preparing such a compound, and therapeutic methods including the administration of such a compound.